Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease

患有危重症 COVID-19 且体内存在针对 I 型干扰素的中和性自身抗体的患者，罹患疱疹病毒疾病的风险增加。